Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines

Oral Oncology

Volumn 44, Issue 7, 2008, Pages 628-633

  Müller Richter, Urs D A ^a   Dowejko, Albert ^a   Zhou, Weiqi ^a   Reichert, Torsten E ^a   Driemel, Oliver ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cancer testis antigens; Keratinocytes; MAGE A antigens; Oral squamous cell carcinoma

Indexed keywords

MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN 6;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL LINE; FETUS CELL; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL LINE; FEMALE; FETUS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MOUTH NEOPLASMS; NEOPLASM PROTEINS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 45249098699     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.08.007     Document Type: Article

References (30)

1. Ochsenbein A.F. Immunological ignorance of solid tumors. Springer Semin Immunopathol 27 1 (2005) 19-35
2. Zitvogel L., Tesniere A., and Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6 10 (2006) 715-727
3. Simpson A.J., Caballero O.L., Jungbluth A., Chen Y.T., and Old L.J. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5 8 (2005) 615-625
4. Zendman A.J., Ruiter D.J., and Van Muijen G.N. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 194 3 (2003) 272-288
5. Scanlan M.J., Simpson A.J., and Old L.J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 23 4 (2004) 1
6. Ferris R.L. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?. ORL J Otorhinolaryng Relat Spec 66 6 (2004) 332-340
7. Melchionda F., McKirdy M.K., Medeiros F., Fry T.J., and Mackall C.L. Escape from immune surveillance does not result in tolerance to tumor-associated antigens. J Immunother 27 5 (2004) 329-338
8. Figueiredo D.L., Mamede R.C., Proto-Siqueira R., Neder L., Silva Jr. W.A., and Zago M.A. Expression of cancer testis antigens in head and neck squamous cell carcinomas. Head Neck 28 7 (2006) 614-619
9. Kienstra M.A., Neel H.B., Strome S.E., and Roche P. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Head Neck 25 6 (2003) 457-463
10. Ries J., Schultze-Mosgau S., Neukam F., Diebel E., and Wiltfang J. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 26 3 (2005) 817-824
11. Barker P.A., and Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 15 (2002) 705-712 67(6)
12. Ohman Forslund K., and Nordqvist K. The melanoma antigen genes-any clues to their functions in normal tissues?. Exp Cell Res 1 (2001) 185-194 265(2)
13. Xiao J., and Chen H.S. Biological functions of melanoma-associated antigens. World J Gastroenterol 10 13 (2004) 1849-1853
14. Guo Z.S., Hong J.A., Irvine K.R., Chen G.A., Spiess P.J., Liu Y., et al. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 15 (2006) 1105-1113 66(2)
15. Wischnewski F., Pantel K., and Schwarzenbach H. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res 4 5 (2006) 339-349
16. Costa F.F., Le Blanc K., and Brodin B. Cancer/Testis antigens, stem cells and cancer. Stem Cells 25 3 (2007) 707-711
17. Alves P.M., Levy N., Bouzourene H., Viatte S., Bricard G., Ayyoub M., et al. Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 56 6 (2007) 839-847
18. Barrow C., Browning J., MacGregor D., Davis I.D., Sturrock S., Jungbluth A.A., et al. Tumor antigen expression in melanoma varies according to antigen and stage. Clin Cancer Res 12 3 Pt 1 (2006) 764-771
19. Haier J., Owzcareck M., Guller U., Spagnoli G.C., Burger H., Senninger N., et al. Expression of MAGE-A cancer/testis antigens in esophageal squamous cell carcinomas. Anticancer Res 26 3B (2006) 2281-2287
20. Choi H.R., Roberts D.B., Johnigan R.H., Sturgis E.M., Rosenthal D.I., Weber R.S., et al. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol 28 10 (2004) 1299-1310
21. Kalejs M., and Erenpreisa J. Cancer/testis antigens and gametogenesis: a review and "brain-storming" session. Cancer Cell Int 5 1 (2005) 4
22. Maruya S., Issa J.P., Weber R.S., Rosenthal D.I., Haviland J.C., Lotan R., et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10 11 (2004) 3825-3830
23. Giono L.E., and Manfredi J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209 1 (2006) 13-20
24. Jungbluth A.A., Ely S., DiLiberto M., Niesvizky R., Williamson B., Frosina D., et al. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood 106 1 (2005) 167-174
25. Duan Z., Duan Y., Lamendola D.E., Yusuf R.Z., Naeem R., Penson R.T., et al. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9 7 (2003) 2778-2785
26. Monte M., Simonatto M., Peche L.Y., Bublik D.R., Gobessi S., Pierotti M.A., et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci USA 103 30 (2006) 11160-11165
27. Higashitsuji H., Itoh K., Nagao T., Dawson S., Nonoguchi K., Kido T., et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 6 1 (2000) 96-99
28. Higashitsuji H., Liu Y., Mayer R.J., and Fujita J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle 4 10 (2005) 1335-1337
29. Dawson S., Higashitsuji H., Wilkinson A.J., Fujita J., and Mayer R.J. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol 16 5 (2006) 229-233
30. Nagao T., Higashitsuji H., Nonoguchi K., Sakurai T., Dawson S., Mayer R.J., et al. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 278 12 (2003) 10668-10674